Hepion Pharmaceuticals will conduct a 1-for-50 reverse stock split effective March 17, 2025, to maintain Nasdaq listing compliance. Hepion Pharmaceuticals, Inc. has announced a 1-for-50 reverse stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback